TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News
Investing
Aurora Cannabis Inc.: The Best Canadian Marijuana Stock?
Investing
Canopy Growth Corp.: Has This Stock Bottomed?
Investing
Should Investors Consider Canopy Growth Corp. at These Levels?
Investing
Looking into the Financials of MedReleaf Corp.
Investing
Could Aurora Cannabis Inc. Lead in Germany?
Investing
Where Does MedReleaf Corp. Place in Marijuana Stock Rankings?
Investing
Sell in May (or June) and Go Away?
Investing
Could MedReleaf Corp. Reignite Interest in the Canadian Marijuana Scene?
Investing
Don’t Get Caught Holding the Bag With Weed Stocks
Investing
When Will Canadian Cannabis Stocks Rebound?
Investing
Is Your Pain Threshold High Enough to Invest in Canadian Marijuana Stocks?